Evidence map›Paper›PMID 34552577›Full record

ArticleFrontiers in microbiology2021

Screening of Fungi for Antimycobacterial Activity Using a Medium-Throughput Bioluminescence-Based Assay.

Alexander B J Grey, Melissa M Cadelis, Yiwei Diao, Duckchul Park, Thomas Lumley, Bevan S Weir, Brent R Copp, Siouxsie Wiles

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Antimicrobial Polyketide Metabolites fromMolecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alexander B J GreyBioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland - Waipapa Taumata Rau, Auckland, New Zealand.
Melissa M CadelisBioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland - Waipapa Taumata Rau, Auckland, New Zealand.
Yiwei DiaoBioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland - Waipapa Taumata Rau, Auckland, New Zealand.
Duckchul ParkManaaki Whenua - Landcare Research, Auckland, New Zealand.
Thomas LumleyDepartment of Statistics, The University of Auckland - Waipapa Taumata Rau, Auckland, New Zealand.
Bevan S WeirManaaki Whenua - Landcare Research, Auckland, New Zealand.
Brent R CoppSchool of Chemical Sciences, The University of Auckland - Waipapa Taumata Rau, Auckland, New Zealand.
Siouxsie WilesBioluminescent Superbugs Lab, Department of Molecular Medicine and Pathology, School of Medical Sciences, The University of Auckland - Waipapa Taumata Rau, Auckland, New Zealand.
University of Auckland · NZManaaki Whenua – Landcare Research · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a real and urgent need for new antibiotics able to kill Mycobacteria, acid-fast bacilli capable of causing multiple deadly diseases. These include members of the

Indexed as

antibacterialbioluminescenceluciferaseminimum inhibitory concentrationmycobacteriaMycobacterium abscessusMycobacterium marinumscreening

Identifiers

PMID34552577
PMCPMC8450596
OpenAlexW3197322129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.